Nasdaq

Viatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR® for the Treatment of Generalized Anxiety ...

--Viatris Inc., a global healthcare company, today announced it has filed applications to the Ministry of Health, Labor and Welfare for approval of Effexor SR Capsules, a serotonin-noradrenaline ...
Nasdaq

Viatris Submits SNDA In Japan For Effexor To Treat Generalized Anxiety Disorder

(RTTNews) - Viatris Inc. (VTRS), a healthcare company, Monday said it has submitted Supplemental New Drug Application to Japan's Ministry of Health, Labor and Welfare (MHLW) for Effexor to treat ...
Morningstar

Viatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR® for the Treatment of Generalized Anxiety Disorder

Aiming to address a significant unmet need for which no other approved treatment option is available for generalized anxiety disorder patients in Japan "The filing of our supplemental New Drug ...
Longview News-Journal

Viatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR® for the Treatment of Generalized Anxiety Disorder

Such forward-looking statements may include statements regarding the receipt or timing of regulatory approvals; the outcome of clinical trials; the filing of our supplemental New Drug Applications is ...